MedPath

University of Zurich

University of Zurich logo
🇨🇭Switzerland
Ownership
Private
Established
1833-04-29
Employees
5K
Market Cap
-
Website
http://www.uzh.ch

Canakinumab for Pyoderma Gangrenosum

Phase 2
Completed
Conditions
Pyoderma Gangrenosum
Interventions
First Posted Date
2011-02-24
Last Posted Date
2016-09-27
Lead Sponsor
University of Zurich
Target Recruit Count
5
Registration Number
NCT01302795
Locations
🇨🇭

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Reproducibility of RNFL Circle Scans With ART-Function of Heidelberg Spectralis SD-OCT Software Version 5.3

Conditions
Glaucoma Patients and Healthy Controls
Interventions
Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H
First Posted Date
2011-02-18
Last Posted Date
2015-01-06
Lead Sponsor
University of Zurich
Target Recruit Count
100
Registration Number
NCT01299233
Locations
🇨🇭

University Hospital Zurich, Ophthalmic Clinic, Zurich, ZH, Switzerland

Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging

Not Applicable
Completed
Conditions
Amphetamine-Related Disorders
Amphetamine Abuse
Interventions
First Posted Date
2011-02-15
Last Posted Date
2011-12-15
Lead Sponsor
University of Zurich
Target Recruit Count
50
Registration Number
NCT01296802
Locations
🇨🇭

University Hospital of Psychiatry Zurich, Zurich, ZH, Switzerland

Choroidal Thickness in Glaucoma Patients and Healthy Controls

Conditions
Glaucoma Patients and Healthy Controls
Interventions
Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H
First Posted Date
2011-02-10
Last Posted Date
2015-01-06
Lead Sponsor
University of Zurich
Target Recruit Count
200
Registration Number
NCT01293474
Locations
🇨🇭

University Hospital Zurich, Ophthalmic Clinic, Zurich, ZH, Switzerland

Lower Urinary Tract Dysfunction Database

Recruiting
Conditions
Neurogenic Bladder
Diseases of the Lower Urinary Tract: General Conditions
First Posted Date
2011-02-10
Last Posted Date
2025-04-03
Lead Sponsor
University of Zurich
Target Recruit Count
7000
Registration Number
NCT01293110
Locations
🇨🇭

Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital, Zürich, Switzerland

Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement

Conditions
Rheumatoid Arthritis
First Posted Date
2011-02-09
Last Posted Date
2012-02-24
Lead Sponsor
University of Zurich
Target Recruit Count
15
Registration Number
NCT01292616
Locations
🇨🇭

University Hospital Zurich, Division of Rheumatology, Zurich, ZH, Switzerland

Evaluation of Filtering Blebs Using the "Wuerzburg Bleb Classification Score" Compared to Other Clinical Findings, e.g. the Intraocular Pressure (IOP)

Completed
Conditions
Glaucoma
First Posted Date
2011-02-01
Last Posted Date
2011-11-04
Lead Sponsor
University of Zurich
Target Recruit Count
100
Registration Number
NCT01287442
Locations
🇨🇭

University Hospital Zurich, Ophthalmic Clinic, Zurich, ZH, Switzerland

Cosmesis and Body Image After Single Port or 4-Port Laparoscopic Cholecystectomy

Not Applicable
Conditions
Symptomatic Gallstone Disease
Interventions
Device: Single Port Cholecystectomy
Device: 4 Port Cholecystectomy
First Posted Date
2011-01-17
Last Posted Date
2011-01-17
Lead Sponsor
University of Zurich
Target Recruit Count
110
Registration Number
NCT01278472
Locations
🇨🇭

University Hospital Zurich, Division of Visceral and Transplantation Surgery, Zurich, Switzerland

Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers

Phase 2
Completed
Conditions
Alzheimer Disease
Interventions
Behavioral: Comprehensive, CBT-based, multi-component treatment
Behavioral: Treatment as usual
First Posted Date
2011-01-10
Last Posted Date
2017-11-06
Lead Sponsor
University of Zurich
Target Recruit Count
50
Registration Number
NCT01273272
Locations
🇨🇭

Psychiatric University Hospital, Clinic for Geriatric Medicine, Zurich, Switzerland

Reproducibility of Nerve Fiber Layer Thickness Measurements in Patients With Glaucoma and Healthy Controls Using Spectral-Domain and Time-Domain OCT

Phase 4
Terminated
Conditions
Glaucoma Patients and Healthy Controls
First Posted Date
2011-01-10
Last Posted Date
2011-01-10
Lead Sponsor
University of Zurich
Target Recruit Count
50
Registration Number
NCT01273285
© Copyright 2025. All Rights Reserved by MedPath